Related posts
Aurora Cannabis, Canopy and More Earnings this Week (Feb 11-15)This week’s new 52-week highs and lows … (Jan 30-Feb 5)Top 8 Canadian Stock Picks under $10 – Growth Stocks, NO Oil, NO Gas, NO MiningThis summary was created by AI, based on 5 opinions in the last 12 months.
Sangoma Technologies Corp. (STC-T) has experienced significant fluctuations in its stock performance over the past year, marked by an impressive spike, a steep decline, and a recent recovery. The new CEO is credited with implementing effective strategies, such as product bundling and a focus on improving margins. Experts believe that the company's previous business structure was not well integrated, but the new management is seen as promising. The consensus among reviewers is that the stock is currently trading at a discount, with strong potential for organic growth of about 10% this year and improved EBITDA margins at 18%. Many experts express optimism about the company's future prospects, citing its now relatively inexpensive valuation compared to peers.
Sangoma Technologies Corp. is a Canadian stock, trading under the symbol STC-T on the Toronto Stock Exchange (STC-CT). It is usually referred to as TSX:STC or STC-T
In the last year, 3 stock analysts published opinions about STC-T. 3 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Sangoma Technologies Corp..
Sangoma Technologies Corp. was recommended as a Top Pick by on . Read the latest stock experts ratings for Sangoma Technologies Corp..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
3 stock analysts on Stockchase covered Sangoma Technologies Corp. In the last year. It is a trending stock that is worth watching.
On 2025-04-15, Sangoma Technologies Corp. (STC-T) stock closed at a price of $6.43.
The chart shows a massive spike up, massive drop, and now recovery in the past year. They likely paid too much for a company in 2022 and were trading at a high PE. He had added shares in 2023-4 after a new CEO started bundling products, focus on margins and integrated companies. Has been doing a good job. He expects them to return to growth this year at 10% organically and 18% EBITDA margins. Looks cheap, half the PE of peers.